Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

H.R. 485 - Protecting Health Care For All Patients Act of 2023 - Rep. McMorris Rodgers, Cathy - federal programs using prices based on quality-adjusted life years
H.R. 824 - Telehealth Benefit Expansion for Workers Act of 2023 - Rep. Walberg, Tim - telehealth and ERISA amendments
H.R. 830 - HELP Copays Act - Rep. Carter, Earl - health insurers responsibility for payments made by or on behalf of a plan enrollee toward a plans cost-sharing requirements
H.R. 1488 - Affordable Insulin Now Act of 2023 - Rep. Craig Angie - cost-sharing for insulin products
H.R. 1613 - Drug Price Transparency in Medicaid Act of 2023 - Rep. Carter, Earl -spread-pricing by PBMs for Medicaid
H.R. 2666 - MVP Act - Rep. Guthrie, Brett - value-based purchasing arrangements under Medicaid program and reforms to price reporting
H.R. 2691 - Transparent Price Act - Rep. McMorris Rodgers, Cathy - health insurer price transparency
H.R. 2813 - Self-Insurance Protection Act - Rep. Good, Bob - ERISA amendments
H.R. 2868 - Association Health Plans Act - Rep. Walberg, Tim - ERISA amendments
H.R. 3305 - Black Maternal Health Momnibus Act - Rep. Underwood, Lauren - maternal health including in Medicaid and CHIP
H.R. 3561 - PATIENT Act - Rep. McMorris Rodgers, Cathy - PBM transparency, PBM contract design, health insurance transparency, hospital transparency
H.R. 3797 - Paperwork Burden Reduction Act - Rep. Smith, Jason - employers mailing 1095 physical tax forms
H.R. 3798 - Small Business Flexibility Act - Rep. Tenney, Claudia - small business coverage notifications
H.R. 3799 - Custom Health Option and Individual Care Expense Arrangement Act- Rep. Hern, Kevin - health reimbursement arrangements
H.R. 3801 - Employer Reporting Improvement Act - Rep. Smith, Adrian - ACA reporting requirements
S. 113 - Prescription Pricing for the People Act of 2023 - Sen. Grassley, Chuck - preventing anti-competitive tactics for prescription drugs
S. 127 - Pharmacy Benefit Manager Transparency Act of 2023 - Sen. Cantwell, Maria - pharmacy benefit manager transparency
S. 652 - Safe Step Act - Sen. Murkowski, Lisa - medication step therapy protocol
S. 954 - Affordable Insulin Now Act of 2023 - Sen. Warnock, Raphael - cost-sharing for insulin products
S. 1038 - Drug Price Transparency in Medicaid Act of 2023 - Sen. Welch, Peter - prohibits spread-pricing by PBMs in Medicaid
S. 1339 - Pharmacy Benefit Manager Reform Act - Sen. Sanders, Bernard - pharmacy benefit managers
S. 1606 - A bill to end preventable maternal mortality, severe maternal morbidity, and maternal health disparities in the United States, and for other purposes. - Sen. Booker, Cory - maternal mortality
Accessible, Affordable Internet for All Act (no bill number) - broadband
Advancing Integration in Medicare and Medicaid (AIM) Act (no bill number) - coordinating full-benefits for dual eligible individuals
Advancing Telehealth Beyond COVID-19 Act (no bill number) - telehealth
American Data Privacy and Protection Act (no bill number) - data privacy
American Rescue Plan Act (no bill number) - COVID-19 relief
Behavioral Health Integration Awareness Act (no bill number) - mental health and Medicare
Better Health Care Directories Act (no bill number) - commercial plans
Building COVID-19 Vaccine Confidence Act (no bill number) - COVID-19
CHOICE Act (no bill number) - public option
CONNECT for Health Act (no bill number) - expansion of telehealth for Medicare
Consolidated Appropriations Act (no bill number) - continued Medicaid and Medicare provisions and funding for FY2023
Consumer Online Privacy Rights Act (no bill number) - data privacy
Continuing Appropriations and Ukraine Supplemental Appropriations Act (no bill number) - continued funding for Medicare and Medicaid
COVID Community Care Act (no bill number) - COVID-19 response
COVID-19 Emergency Telehealth Impact Reporting Act (no bill number) - telehealth and COVID-19
COVID-19 Health Disparities Action Act (no bill number) -COVID-19 and health disparities
Data Mapping to Save Moms Lives Act (no bill number) - maternal health data
Equitable Data Collection and Disclosure on COVID-19 Act (no bill number) - COVID-19 Data Collection
Fighting Stimulant and other Substance Use Disorders Act (no bill number) - mental health and Medicare
Food and Drug Amendments (no bill number) - reauthorization of user fee programs
Health Care Improvement Act (no bill number) - care costs and coverage
Hospital Competition Act (no bill number) - procedural changes around The Mental Health Parity and Addiction Equity Act (MHPEA) litigation
IMPACT to Save Moms Act (no bill number) - maternal health
Improving Access to Behavioral Health Integration Act (no bill number) - behavioral health
Improving Access to Health Care in Rural and Underserved Areas Act (no bill number)- rural health
Improving Seniors Timely Access to Care Act (no bill number) - prior authorization in Medicare Advantage
Improving Social Determinants of Health Act (no bill number) - health disparities
Inpatient Psychiatric Facility Improvement Act (no bill number) - mental health and Medicare
Kira Johnson Act (no bill number) - maternal health
LIFT America Act (no bill number) - broadband and public health infrastructure
Lower Costs, More Cures Act (no bill number) - prescription drug prices for Medicare and Medicaid
Maternal Vaccinations Act (no bill number) - maternal health
Medicaid Saves Lives Act (no bill number) - Medicaid expansion
Medicare for All Act (no bill number) - public option
Medicare Multi-Cancer Early Detection Screening Coverage Act (no bill number) - Cancer screening in Medicare
Mental Health Matters Act (no bill number) - changes to the procedure around MHPEA litigation
MOMMAs Act (no bill number) - maternal health
Moms Matter Act (no bill number) - maternal mental health conditions and SUD
MORE Health Education Act (no bill number) - Federal Exchange outreach and educational activities
NO PAIN Act (no bill number) - non-opioid treatment
No Surprises for Survivors Act (no bill number) - requirements for group health plans and health insurance issuers offering group or individual health insurance coverage to provide coverage for forensic medical exams with no cost sharing
Nursing Home Reform Modernization Act (no bill number) - nursing home quality and transparency
Parity Enforcement Act (no bill number) - mental health and SUD
Parity Implementation Assistance Act (no bill number) - mental health parity
PATCH Act (no bill number) - privacy and cybersecurity
Patients Before Middlemen Act (no bill number) - pharmacy benefit managers
Physician Wellness Program Act (no bill number) - mental health and Medicare
Prevent Pandemics Act (no bill number) - pandemic preparedness
Preventing Mental Health and Substance Use Crises During Emergencies Act (no bill number) - mental health and SUD national strategy
Promoting Clarity in Mental Health and Substance Use Disorder Treatment Act (no bill number) - commercial plans
Protecting Americans with Pre-Existing Conditions Act (no bill number) - state innovation waivers
Protecting Patients from Deceptive Health Plans Act (no bill number) - excepted benefits coverage
Protecting Personal Health Data Act (no bill number) - privacy
Public Health Infrastructure Saves Lives Act (no bill number) - public health infrastructure
Public Option Deficit Reduction Act (no bill number) - public option
Restore Protections for Dialysis Patients Act (no bill number) - reform of MSP Secondary Payer Act
Restoring Hope for Mental Health and Well-Being Act (no bill number) - reauthorization of several behavioral health programs
RICE Act (no bill number) - commercial plans
SAFE DATA Act (no bill number) - consumer data privacy and data transparency and security
Safe Step Act (no bill number) -commercial plans and medication step-therapy requirements
Secure Data and Privacy for Contact Tracing Act (no bill number) - digital contact tracing for COVID-19
Social Determinants for Moms Act (no bill number) - SDOH and maternal health
Strengthen Kids Mental Health Now Act (no bill number) - mental health and Medicaid
Supporting Best Practices for Healthy Moms Act (no bill number) - maternal health
Tech to Save Moms Act (no bill number) - maternal health
The Jackie Walorski Maternal and Child Home Visiting Reauthorization Act (no bill number) - funding for maternal and early childhood health programs
To amend the Consolidated Appropriations Act, 2021 to authorize additional funds for the Emergency Broadband Connectivity Fund, to provide grants to States and Tribal Entities to strengthen the National Lifeline Eligibility Verifier, to provide for Federal coordination between the National Lifeline Eligibility Verifier and the National Accuracy Clearinghouse (no bill number) - Broadband
To amend the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to require group health plans and health insurance issuers offering group or individual health insurance coverage to disclose the percentage of in-network participation for certain provider types, and for other purposes. (no bill number) - commercial plans
To amend title XI of the Social Security Act to require CMI testing of incentive payments for behavioral health providers and certain other providers for adoption and use of certified electronic health record technology, and for other purposes. (no bill number) - behavioral health and electronic health records
To amend title XVIII of the Social Security Act to ensure adequate coverage of outpatient mental health services under the Medicare program. (no bill number) - mental health and Medicare
To direct the Secretary of Health and Human Services to conduct a public outreach campaign to inform individuals covered under a group health plan or group or individual health insurance coverage of Federal requirements relating to mental health and substance use disorder crisis services, and for other purposes. (no bill number) - commercial plans
To direct the Secretary of Health and Human Services to provide outreach and reporting on opioid use disorder treatment services furnished by opioid treatment programs under the Medicare program. (no bill number) - mental health and Medicare
TREATS Act (no bill number) - increase use of telehealth for SUD treatment
Turn the Tide Act (no bill number) - Substance Use Disorder
Virtual Community Support Act (no bill number) - mental health and SUD grants for community peer support
Issues related to broadband and public health infrastructure; mental health and telehealth; COVID-19 testing; public option programs; behavioral health; rural health; substance use disorder treatments; Health Savings Accounts; and provider directories.

Regulatory Issues:
HIPAA administrative simplification issues, including standards for privacy, security, and electronic transactions and code sets (including ICD-10 and ICD-11), identifiers, enforcement; cybersecurity; issues related to Medicare Secondary Payer requirements; issues related to health care price transparency; issues related to all payor claims databases; issues related to implementation of the National Health Information Infrastructure; electronic health records, personal health records, and similar technologies; issues relating to market consolidation; issues related to hospital and provider consolidation; issues related to medical management; issues relating to quality improvement; issues relating to the national health data stewardship; issues relating to hospital outpatient measurement and reporting; issues relating to COVID-19, including testing, vaccines and therapeutics; issues related to the end of the public health emergency; issues related to health equity; issues related to vaccination; issues related to addressing the social determinants of health, including housing, transportation, nutrition, and educational opportunities; prescription drug pricing; telehealth; issues related to the cost of insulin, including price, copays, rebates, and medical management tools; rural health; issues related to behavioral health benefits; issues related to Managed Long Term Services and Supports (MLTSS); issues related to the collection of race and ethnicity data; issues related to medical loss ratios; reference pricing; review of rates for reasonableness; preexisting condition insurance plans; issues relating to antitrust; issues relating to surprise medical bills; accountable care organizations; provider non-discrimination; coverage of preventive services; contraceptive coverage and reproductive health; pre-existing condition exclusions; lifetime and annual dollar limits on benefits; patient protections; grandfathered health plan provisions; issues related to health insurance tax; health plan automatic enrollment requirements; issues related to qualified health plans including certification and rate filing templates; health insurance market rules; ACA risk adjustment; dependent coverage; summary of benefits and coverage disclosures; benefit and payment parameters; essential health benefits, actuarial value, and accreditation; NQF reauthorization; issues related to fraud, waste, abuse, Stark/Anti-Kickback laws and regulations; issues related to supplemental products; issues related to HIPAA excepted benefits; issues related to short term limited duration products; issues related to the federally-facilitated marketplaces (i.e., Exchanges/formerly referred to as the web portal); issues related to business continuity in relation to pandemics or natural events (e.g., hurricane, tornado, etc.); issues related to association health plans; issues related to cost-sharing reductions (CSRs); issues related to the refundable credit for coverage under a qualified health plan and enhancements included in the American Rescue Plan Act (ARPA); issues related to Medicaid coverage gap; issues related to small employer group size; issues related to Certificate of Public Advantage; issues relating to veterans health care; issues relating to caregivers; and other issues relating to health care reform implementation.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), Labor - Dept of (DOL), White House Office

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

H.R. 3746 - Fiscal Responsibility Act of 2023 - Rep. McHenry, Patrick - work requirements for federal programs
Addressing Social Determinants in Medicare Advantage Act (no bill number) - Medicare Advantage supplemental benefits
Advancing Enrollment and Reducing Drug Costs Act (no bill number) - Medicaid eligibility for low-income subsidies
Affordable Insulin for the COVID-19 Emergency Act (no bill number) - cost-sharing regarding insulin coverage
CAHOOTS Act (no bill number) - Medicaid mobile crisis intervention services
CARING for Kids Act (no bill nunber) - CHIP
CHIPP Act (no bill number) - extending CHIP
CHIPPER Act (no bill number) - CHIP funding
Close the Medigap Act (no bill number) - Medigap policies
COMP Act (no bill number) - Medicare secondary payer rules
Continued Funding for Senior Services During COVID-19 Act (no bill number) - funding for services under the Older Americans Act of 1965
Coronavirus Medicaid Response Act (no bill number)- FMAP
Dosha Joi Immediate Coverage for Former Foster Youth Act (no bill number) - Medicaid coverage for foster youth
Ensuring Kids Have Access to Medically Necessary Dental Care Act (no bill number) - dental coverage under CHIP
Ensuring Parity in MA and PACE for Audio-Only Telehealth Act (no bill number) - Medicare Advantage payments for audio-only diagnoses
Ensuring Parity in MA for Audio-Only Telehealth Act (no bill number) - coverage of audio-only telehealth services in MA
Expand Medicaid Now Act (no bill number) - FMAP
Expanded Telehealth Access Act (no bill number) - Medicare payment for telehealth services
Fairness in Medicare Part B Enrollment (no bill number) - late enrollment penalties under part B of the Medicare program
Foster Youth Dental Act (no bill number) - Medicaid dental coverage for foster youth
HAPI Act (no bill number) - access to vaccines and Medicaid
Health Insurance Consumer Protection Act (no bill number) - network adequacy standards and premium rates
Immediate Coverage for Former Foster Youth Act (no bill number) - Medicaid coverage for foster youth
Improving Access to Mental Health Act (no bill number) - mental health services in Medicare
Incentivizing Medicaid Expansion Act (no bill number) - Medicaid expansion
Insular Area Medicaid Parity Act (no bill number) - Medicaid funding
Jack Reynolds Memory Medigap Expansion Act (no bill number) - Medigap coverage for ESRD
KEEP Telehealth Options Act (no bill number) - telehealth expansion
Medicaid REACH Act (no bill number) - requirements for non-expansion
Medicaid Reentry Act (no bill number) - Medicaid coverage for incarcerated individuals
Medicare Advantage Integrity Act (no bill number) - disparity in MA benchmark rates
Medicare Dental Benefit Act (no bill number) - Medicare coverage of dental and oral health services
Medicare Sequester COVID Moratorium Act (no bill number) - Medicare sequestration
Medicare Sequester Relief Act (no bill number) - Medicare payment sequestration
Medicare-X Choice Act (no bill number) - Medicare public option
Mental Health Access Improvement Act (no bill number) - Medicare coverage of marriage and family therapist services and mental health counselor
Patient Empowerment Act (no bill number) - Medicaid payment options
Protecting Married Seniors from Impoverishment Act (no bill number) - permanent protections against spousal impoverishment
Puerto Rico Health Care Fairness, Accountability, and Beneficiary Access Act (no bill number)- Medicaid in Puerto Rico
Rural Behavioral Health Access Act (no bill number) - Medicare coverage of outpatient telehealth services
Rural Hospital Closure Relief Act (no bill number) - Medicare coverage for critical access hospitals
Rural Hospital Support Act (no bill number) - Medicare payments for hospitals
RUSH Protection Act (no bill number) - Medicare rural health clinic payments
SAME Act (no bill number) - Medicaid expansion
SAVE Act (no bill number) - Medicare coverage of transportation services
Save Rural Hospitals Act (no bill number) - Medicare hospital payments
Stabilize Medicaid and CHIP Coverage Act (no bill number) - Medicaid and CHIP continuous enrollment
Stronger Medicaid Response to the COVID-19 Pandemic Act (no bill number) - COVID-19 coverage for the uninsured via Medicaid
Telehealth Modernization Act (no bill number) - coverage of telehealth services under Medicare
Territories Medicare Prescription Drug Assistance Equality Act (no bill number) - Medicare Part D premium and cost-sharing subsidies
Territory Federal Matching Requirement Equity Act (no bill number) - Medicaid FMAP for Territories
The COVID-19 Hospital and Health Provider Loan Conversion Act (no bill number) - advance payments under parts A and B of Medicare
TIKES Act (no bill number) - CHIP
To amend the Deficit Reduction Act of 2005 to make permanent the Money Follows the Person Rebalancing Demonstration (no bill number) - Money Follows the Person Rebalancing Demonstration
To amend title XIX of the Social Security Act to remove the matching requirement for a territory to use specially allocated Federal funds for Medicare covered part D (no bill number) - Medicare covered part D
Treatment in Place Act (no bill number) - Medicare coverage of ambulance services
Issues related to mental health and Medicare; Medicare and Medicaid funding; Medicaid expansion; State innovation waivers; Medicaid and CHIP; and Medicaid FMAP.

Regulatory Issues:
Ongoing implementation issues for the Medicare Advantage (MA) and Medicare Part D prescription drug programs, including risk adjustment methodology, network adequacy and provider directories, encounter data and other data-related issues, and risk adjustment data validation (RADV) audit issues including RADV regulation for MA; bidding and payment issues (including MA rate assumptions, MA coding intensity, MA Secondary Payer issues, Part D reinsurance, Part D low income subsidies, Part D direct and indirect remuneration (DIR), and audits); issues related to Medicare for All, Medicare buy-in, reduced Medicare eligibility age, and public option; issues relating to 2024 Rate Notice; issues related to the expiration of Medicaid continuous eligibility and transitions in coverage; issues related to coverage in non-Medicaid Expansion States (e.g., Gap Population); issues related to expanded Medicare fee for service benefits (dental, hearing and vision); issues related to specialty infant formula; issues related to the Inflation Reduction Act implementation; contraceptive coverage and reproductive health; Medicare NCD relating to monoclonal antibodies for treatment of Alzheimers disease; issues related to Managed Long Term Services and Supports (MLTSS); issues relating to COVID-19, including testing, vaccines and therapeutics; issues related to the end of the public health emergency, including the Medicaid unwinding; telehealth; issues related to the cost of insulin, including price, copays, rebates, and medical management tools; issues related to health equity; issues related to vaccination; issues related to audio-only telehealth; issues related to addressing the social determinants of health, including housing, transportation, nutrition, educational opportunities, and MA supplemental benefits; issues related to Medicaid presumptive eligibility and continuous eligibility; issues relating to Medicaid best price; in-home health risk assessments; Medicare Medical Loss Ratio issues; issues related to changes to prior authorization regulations or legislation, electronic documentation, and related issues; issues relating to sequestration under the Medicare Advantage and Part D programs; implications of physician fee schedule on MA; application process, audits to evaluate compliance with MA and Part D program rules, benefit design rules, enrollment rules, requirements for notice and denial forms, marketing materials review and approval, marketing activities, including conduct and compensation of brokers and agents and plan sponsor marketing staff; measurement and oversight of plan performance including Special Needs Plans (SNPs); quality measures, grievance and appeals processes, fraud and abuse compliance including training; contracting issues for Dual Eligible SNPs; Federal preemption of State authority under MA and Part D programs, Part D prescription drug event data reporting, Part D formulary rules, Part D pharmacy access standards, Part D coverage gap discount program, including employer group waiver plan (EGWP) issues, and other operational issues; issues raised by Part D coverage of new specialty drugs, the Part D non-interference policy and related issues (e.g., preferred pharmacy and any willing pharmacy requirements, standards for network pharmacy reimbursement, and policies regarding sponsor negotiation of pharmacy price concessions); issues related to the international price index; issues related to child and maternal health; issues related to Medicaid supplemental and disproportionate share hospital (DSH) funding; issues related to Medicaid funding for territories; issues related to medical management; issues relating to MA supplemental benefits; Medication Therapy Management Program requirements and the Center for Medicare and Medicaid Innovation (CMMI) Demonstration; MA EGWP issues; CMMI's value based payment models; Part D requirements for offering basic and enhanced alternative plans; MA and Part D systems issues affecting enrollment and disenrollment processing and payment and other operational issues; issues relating to MA and Part D Star Rating system including measures, the methodology for calculating ratings, and the role of the ratings for payment purposes; functionality of the Medicare Personal Plan Finder and Drug Plan Finder; National Medicare Education Program; Medicare demonstration program on performance-based payments for physician groups; physician quality reporting initiative; issues relating to Medicare coverage policy and national coverage decisions; issues relating to MACRA, including implications for MA and Part D plans; Medicare/Medicaid integration for dual eligibles, including implementation of the Capitated Financial Alignment Demonstration and related issues (e.g., quality ratings); issues relating to potential Medicare mental health parity requirements; Medicaid managed care regulations and policies, including the Medicaid managed care actuarial soundness standard, quality oversight, Medicaid and CHIP Payment and Access Commission (MACPAC), grievance and appeals processes, fraud and abuse compliance, beneficiary information requirements, treatment of Medicaid health plan member hospital days in the upper payment limit calculation; policies affecting State Medicaid funding, including block grants, the calculation of the federal medical assistance (federal matching) percentage (FMAP), and intergovernmental transfers (IGTs); coordination of benefits with state Medicaid programs; Medicaid prescription drug cost issues affecting Medicaid health plans including issues raised by Medicaid coverage of new specialty drugs; health plan-related Childrens Health Insurance Program (CHIP) issues, including eligibility and outreach issues and CHIP reauthorization; implementation of Medicaid changes made in Deficit Reduction Act of 2005, including Medicaid managed care organization provider tax issues; standards for electronic prescribing; issues related to Medicaid Managed long-term care including home and community-based waiver services (HCBS); expanding the availability of Medicare Advantage and Medicaid health plan telemedicine programs; implications of the new non-discrimination rules for health plans participating in public programs; issues related to Medigap coverage; issues related to business continuity in relation to pandemics or natural events (e.g., hurricane, tornado, etc.); cybersecurity; provider directories; value-based insurance design models; Part D prescriber enrollment requirements; Part D recovery audit contractor programs; issues related to health homes for children with medically complex conditions; socioeconomic status impacts on star ratings related to MA and Part D programs; issues related to private equity ownership transparency; and other issues relating to health care reform implementation.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Executive Office of the President (EOP), White House Office, Congressional Budget Office (CBO)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code INS

16. Specific lobbying issues

Continuing Coverage for Preexisting Conditions Act (no bill number) -preexisting conditions
ENROLL Act (no bill number) - navigator program
Ensuring Coverage in Public Health Emergencies Act (no bill number) - SEP
Ensuring Lasting Smiles Act (no bill number) - diagnosis and treatment of a congenital anomaly or birth defect
Expand Navigators Resources for Outreach, Learning, and Longevity Act (no bill number) - navigator program
Expanded Coverage for Former Foster Youth Act (no bill number) - coverage for foster youth
Fair Indexing for Health Care Affordability Act (no bill number) - MOOP & premium tax credit eligibility
Health Care Enrollment Innovation Act (no bill number) - state innovations and insurance coverage
Health Savings Act (no bill number) - HSAs
Improving Health Insurance Affordability Act (no bill number) - cost-sharing subsidies
No Junks Plans Act (no bill number) - Short-Term, Limited Duration Insurance
No Surprises for COVID-19 Tests Act (no bill number) - COVID-19 test coverage
Pre-existing Conditions Protection Act (no bill number) - preexisting conditions
Premium Relief Act (no bill number) - Patient and State Stability Fund
State Health Care Premium Reduction Act (no bill number) - affordability
Strengthening Rural Health Clinics Act (no bill number) - rural health clinic payments
Tele-Mental Health Improvement Act (no bill number) - telehealth parity in mental health and SUD coverage
To amend title XXVII of the Public Health Service Act to eliminate the short-term limited duration insurance exemption with respect to individual health insurance coverage (no bill number) - short-term limited duration insurance
To amend title XIX of the Social Security Act to remove the matching requirement for a territory to use specially allocated Federal funds for Medicare covered part D (no bill number) - Medicare covered part D
Worker Health Coverage Protection Act (no bill number) - coverage continuity & COBRA

Regulatory Issues:
Insurance regulatory reform; issues related to the coordination of private and public disability income benefits; disability risk management; disability income insurance enrollment and awareness; issues related to COBRA continuation coverage; issues related to the expiration of Medicaid continuous eligibility and transitions in coverage; issues related to child and maternal health; benefit and payment parameters; issues related to behavioral health benefits; issues related to encouraging impaired workers to stay in/return to the workforce; issues related to expanding long-term care insurance coverage; issues relating to COVID-19, including testing, vaccines and therapeutics; issues related to the cost of insulin, including price, copays, rebates, and medical management tools; issues related to health equity; issues related to vaccination; issues related to coverage in non-Medicaid Expansion States (e.g., Gap Population); issues related to the No Surprises Act, enacted as part of the Consolidated Appropriations Act in December 2020, including disclosure of agent broker compensation (Section 202c); issues related to addressing the social determinants of health, including housing, transportation, nutrition, and educational opportunities; issues related to changes to prior authorization regulations, electronic documentation, and related issues; issues related to specialty infant formula; issues related to coverage of crisis services; issues related to kidney dialysis; issues relating to Medicaid best price; issues relating to the coordination of benefits between private health insurance plans and Medicaid; Medigap claims processing and crossover fees; Medigap cross-over claim issues, Medigap coverage, implementation of Medigap standardized plan offerings; Medigap carrier recoveries related to CMS fraud and abuse enforcement activities, and issues related to Medigap educational materials, and other Medigap issues; fraud and abuse issues affecting public and private insurance coverage; issues relating to antitrust; implementation of the Mental Health Parity Act requirements; implementation of the 21st Century Cures Act requirements; summary of benefits and coverage disclosures; prior authorization; accountable care organizations; coverage of preventive services; contraceptive coverage and reproductive health; preexisting condition exclusions; lifetime and annual dollar limits on benefits; patient protections; grandfathered health plan provisions; health reimbursement accounts; dependent coverage; treatment of expatriate plans; issues related to surprise medical bills; issues related to all payor claims databases; issues related to association health plans; issues related to substance abuse and provider treatment records (42 CFR Part 2); issues related to medical management; issues related to fraud, waste, abuse, Stark/Anti-Kickback laws and regulations, non-discriminatory wellness programs; issues related to supplemental products; issues relating to dental coverage; issues relating to proposals for single-payer and Medicare/Medicaid buy-in options; issues related to implementation of the Telephone Consumer Protection Act; issues relating to third party payment of premiums; issues related to cost-sharing reductions (CSRs); issues related to interoperability and price transparency; issues related to the employer market; issues relating to the individual market; and other issues relating to health care reform implementation.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP), Health & Human Services - Dept of (HHS), Labor - Dept of (DOL), Centers For Medicare and Medicaid Services (CMS), White House Office

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code PHA

16. Specific lobbying issues

H.R. 1488 - Affordable Insulin Now Act of 2023 - Rep. Craig Angie - cost-sharing for insulin products
H.R. 1613 - Drug Price Transparency in Medicaid Act of 2023 - Rep. Carter, Earl -spread-pricing by PBMs for Medicaid
H.R. 2691 - Transparent Price Act - Rep. McMorris Rodgers, Cathy - health insurer price transparency
H.R. 3561 - PATIENT Act - Rep. McMorris Rodgers, Cathy - PBM transparency, PBM contract design, health insurance transparency, hospital transparency
S. 79 - Interagency Patent Coordination and Improvement Act of 2023 - Sen. Durbin, Richard - prescription drug patenting
S. 113 - Prescription Pricing for the People Act of 2023 - Sen. Grassley, Chuck - preventing anti-competitive tactics for prescription drugs
S. 127 - Pharmacy Benefit Manager Transparency Act of 2023 - Sen. Cantwell, Maria - pharmacy benefit manager transparency
S. 142 - Preserve Access to Affordable Generics and Biosimilars Act - Sen. Klobuchar, Amy - pharmacy and biosimilar prescription drugs
S. 148 - Stop STALLING Act - Sen. Klobuchar, Amy - pharmacy market approval processes
S. 150 - Affordable Prescriptions for Patients Act of 2023 - Sen. Cornyn, John - pharmacy and prescription drug prices
S. 574 - Increasing Prescription Drug Competition Act - Sen. Hassan, Maggie - closure of pharmaceutical patent loophole
S. 954 - Affordable Insulin Now Act of 2023 - Sen. Warnock, Raphael - insulin pricing and cost sharing
S. 1038 - Drug Price Transparency in Medicaid Act of 2023 - Sen. Welch, Peter - prohibits spread-pricing by PBMs in Medicaid
S. 1339 - Pharmacy Benefit Manager Reform Act - Sen. Sanders, Bernard - pharmacy benefit managers
Biosimilar Red Tape Elimination Act (no bill number) - pharmacy and biosimilar prescription drugs
Empowering Medicare Seniors to Negotiate Drug Prices Act (no bill number) -Medicare drug prices
Fairness in Orphan Drug Exclusivity Act (no bill number) - orphan drugs
Increasing Transparency in Generic Drug Applications Act (no bill number) - cuts red tape for generics to come to market
Medicare Drug Price Negotiation Act (no bill number) - Drug Prices
Patent Eligibility Restoration Act (no bill number) - patent changes
Protecting Consumer Access to Generic Drugs Act (no bill number) - patent infringement settlements

Regulatory Issues:
Issues relating to long term safety and effectiveness of medical devices and drugs, including registries; issues relating to post-market surveillance of drugs and medical devices; issues relating to price of drugs and biologics and proposals to limit high prices; issues related to prescription drug coupons and discount programs; contraceptive coverage; issues relating to vaccines; issues related to health equity; issues related to vaccination; potential Medicare NCD relating to monoclonal antibodies for treatment of Alzheimers disease; issues related to coverage of EUA drugs under Medicare Part D; issues related to drug patents and market exclusivity; issues related to pharmacy benefit managers; issues related to biosimilars; issues related to approval of drugs and biologics; issues relating to opioids; issues relating to COVID-19, including testing, vaccines and therapeutics; issues related to health care price transparency; issues relating to prescription drug rebates; direct-to-consumer advertising for prescription drugs; issues relating to access for investigational drugs; issues related to comparative effectiveness research and quality-adjusted life years; issues related to health plan step-therapy; and other issues relating to health care reform implementation.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Executive Office of the President (EOP), White House Office, Congressional Budget Office (CBO)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TAX

16. Specific lobbying issues

H.R. 1843 - Telehealth Expansion Act of 2023 - Rep. Steel, Michelle - exemption of high deductible health plans from the requirement of a deductible for telehealth and other remote care services
S. 1001 - Telehealth Expansion Act of 2023 - Sen. Daines, Steve - exemption of high deductible health plans from the requirement of a deductible for telehealth and other remote care services
Health Care Affordability Act (no bill number) - tax credits
Responsible Additions and Increases To Sustain Employee Health Benefits Act (no bill number) - health savings accounts

Regulatory Issues:
Issues concerning the patient-centered outcomes research fee; issues related to the employer shared responsibility payment (i.e., employer coverage mandate); W-2 reporting requirements; health reimbursement accounts; deductibility limits for insurer compensation; issues relating to COVID-19; issues related to electronic notices; health insurer and employer reporting of health coverage; issues related to the refundable credit for coverage under a qualified health plan; issues related to coverage of chronic conditions in high deductible health plans; issues related to coverage of telehealth in high deductible health plans; issues related to health savings accounts; issues related to the deductibility of employer-sponsored health coverage; issues related to enhancing tax treatment of long-term care insurance; issues related to coverage in non-Medicaid Expansion States (e.g., Gap Population); issues related to qualified small employer health reimbursement accounts (QSEHRAs); and other issues relating to health care reform implementation.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address: https://www.ahip.org/board-of-directors

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
No Yes